LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | PD173074 | 10 | uM | LJP6 | 3 | I07 | 72 | hr | 765 | 874 | 3066 | 0.2851 | 0.0687 |
Hs 578T | Crizotinib | 0.04 | uM | LJP5 | 1 | A24 | 72 | hr | 765 | 3164 | 3140 | 1.0075 | 1.0074 |
Hs 578T | Crizotinib | 0.04 | uM | LJP5 | 2 | A24 | 72 | hr | 765 | 3183 | 3151 | 1.0099 | 1.0097 |
Hs 578T | Crizotinib | 0.04 | uM | LJP5 | 3 | A24 | 72 | hr | 765 | 3211 | 3152 | 1.0186 | 1.0181 |
Hs 578T | Crizotinib | 0.12 | uM | LJP5 | 1 | A23 | 72 | hr | 765 | 3116 | 3140 | 0.9922 | 0.9924 |
Hs 578T | Crizotinib | 0.12 | uM | LJP5 | 2 | A23 | 72 | hr | 765 | 3080 | 3151 | 0.9773 | 0.9776 |
Hs 578T | Crizotinib | 0.12 | uM | LJP5 | 3 | A23 | 72 | hr | 765 | 3110 | 3152 | 0.9865 | 0.9868 |
Hs 578T | Crizotinib | 0.37 | uM | LJP5 | 1 | A22 | 72 | hr | 765 | 2830 | 3140 | 0.9012 | 0.9004 |
Hs 578T | Crizotinib | 0.37 | uM | LJP5 | 2 | A22 | 72 | hr | 765 | 2935 | 3151 | 0.9313 | 0.9315 |
Hs 578T | Crizotinib | 0.37 | uM | LJP5 | 3 | A22 | 72 | hr | 765 | 2839 | 3152 | 0.9006 | 0.9001 |
Hs 578T | Crizotinib | 1.11 | uM | LJP5 | 1 | A21 | 72 | hr | 765 | 2496 | 3140 | 0.7948 | 0.7868 |
Hs 578T | Crizotinib | 1.11 | uM | LJP5 | 2 | A21 | 72 | hr | 765 | 2827 | 3151 | 0.8970 | 0.8963 |
Hs 578T | Crizotinib | 1.11 | uM | LJP5 | 3 | A21 | 72 | hr | 765 | 2781 | 3152 | 0.8822 | 0.8810 |
Hs 578T | Crizotinib | 3.33 | uM | LJP5 | 1 | A20 | 72 | hr | 765 | 1623 | 3140 | 0.5168 | 0.4465 |
Hs 578T | Crizotinib | 3.33 | uM | LJP5 | 2 | A20 | 72 | hr | 765 | 1458 | 3151 | 0.4626 | 0.3713 |
Hs 578T | Crizotinib | 3.33 | uM | LJP5 | 3 | A20 | 72 | hr | 765 | 1769 | 3152 | 0.5612 | 0.5073 |
Hs 578T | Crizotinib | 10 | uM | LJP5 | 1 | A19 | 72 | hr | 765 | 656 | 3140 | 0.2089 | -0.0727 |
Hs 578T | Crizotinib | 10 | uM | LJP5 | 2 | A19 | 72 | hr | 765 | 746 | 3151 | 0.2367 | -0.0123 |
Hs 578T | Crizotinib | 10 | uM | LJP5 | 3 | A19 | 72 | hr | 765 | 584 | 3152 | 0.1853 | -0.1238 |
Hs 578T | BMS345541 | 0.04 | uM | LJP6 | 1 | D06 | 72 | hr | 765 | 3044 | 3143 | 0.9683 | 0.9686 |
Hs 578T | BMS345541 | 0.04 | uM | LJP6 | 2 | D06 | 72 | hr | 765 | 3084 | 3095 | 0.9962 | 0.9963 |
Hs 578T | BMS345541 | 0.04 | uM | LJP6 | 3 | D06 | 72 | hr | 765 | 3118 | 3066 | 1.0170 | 1.0169 |
Hs 578T | BMS345541 | 0.12 | uM | LJP6 | 1 | D05 | 72 | hr | 765 | 3093 | 3143 | 0.9839 | 0.9841 |
Hs 578T | BMS345541 | 0.12 | uM | LJP6 | 2 | D05 | 72 | hr | 765 | 3064 | 3095 | 0.9898 | 0.9898 |
Hs 578T | BMS345541 | 0.12 | uM | LJP6 | 3 | D05 | 72 | hr | 765 | 2951 | 3066 | 0.9625 | 0.9622 |